Laura L. Singletary is an associate at Simmons Hanly Conroy LLC in the Pharmaceutical Litigation Department. Based out of the New York office, her primary practice is in the area ...
Recent research has linked low testosterone
treatments such as Androgel, Androderm, Axiron, Delatestryl, Fortesta, Testopel and more to an increased risk of heart attack, stroke or death when taken by men with heart problems.
At Simmons Hanly Conroy, we’re dedicated to our clients and communities. We have donated nearly $20 million to cancer research, and we support a variety of organizations including the American Lung Association, American Red Cross, Salvation Army and more.
Simmons Hanly Conroy is a national law firm with offices in Chicago, St. Louis, San Francisco, Los Angeles, New York and Alton, Illinois. We have the resources necessary to prosecute pharmaceutical drug and device ligation. We are also dedicated to giving our clients the personal attention and the respect they deserve, no matter where they live.
January 6, 2016 - Mesh Implants to Receive Stricter Oversight from FDA
Articles & analysis from the Firm attorneys and staff.
October 26, 2015 - The History of Risperdal in the Pharmaceutical Marketplace
July 16, 2015 - Is Testosterone Replacement Therapy Safe? What You Need to Know